Abstract 17: A Comparison of Receptor Specificity on Infantile Hemangioma Gene Expression and Microvascular Density

Plastic and Reconstructive Surgery - Global Open: April 2016 - Volume 4 - Issue 4S - p 10
doi: 10.1097/01.GOX.0000488887.12802.95
PRS AAPS Oral Proofs 2016

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.

James E. McCarthy, MD, Timothy W. King, MD, PhD

From the University of Wisconsin-Madison, Madison, Wis.

PURPOSE: Infantile hemangiomas demonstrate involution after oral and topical β blockers. We sought to determine (1) administration route on tumor involution, (2) β receptor selectivity on gene expression, and (3) effect of mesenchymal cell type on gene expression.

METHODS: Human infantile hemangioma endothelial stem cells (HemESCs) and endothelial cells were grown to 90% confluence, and media was exchanged to 50 μg/μl and 100 μg/μl concentrations of metoprolol (β-1 blocker) and propranolol (nonselective β blocker), respectively, for 72 hours. Reverse transcription polymerase chain reaction was used to assess gene expression of HIF-a, VEGF-a, VEGF-a1 receptor, VEGF-a2 receptor, and PDGF-β. The dorsum of 8-week-old nude athymic mice were injected with 200 μl of HemESCs and human infantile hemangioma endothelial cells in matrigel at 1 × 106 cells/μl per cell line. Six mice per β blocker per route were treated with 0.2 mg/kg oral, local injection of 0.2 mg/kg, or 1% topical preparations twice daily for 2 weeks during when tumors were explanted. Differences in tumor volume and microvascular density were analyzed.

RESULTS: HemESCs exposed to propranolol had a 1.5-fold reduction in expression of HIF-a and VEGF-a in a dose-dependent manner (P = 0.05). There were no differences in tumor volume between administration routes; however, oral administration trended toward greater reduction in microvascular density (P = 0.08).

CONCLUSIONS: Nonselective β blockade leads to greater inhibition of HIF-a and VEGF-a compared with selective β blockade, particularly in HemESCs. Oral administration of β blockers appears to produce greater reduction in microvascular density.

© 2016 American Society of Plastic Surgeons